---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-004783"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2024-02-02T23:59:59+00:00"
generated_at: "2026-06-06T10:27:43.116238+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncotelic completes $0.5M debt conversion and issues 12 convertible note units

## Summary
- Issued 12 units each with a $25,000 convertible note (convertible at $0.10/share) and warrants to buy 250,000 shares at $0.12/share.
- Converted $500,000 of debt from 4 accredited investors under prior private placement into Subscription Agreements.
- Paid $45,000 placement agent fees to JH Darbie & Co., which also earned 13% of warrants issued.
- This fourth tranche concludes conversion of all notes from prior private placement; company hopes to raise additional funds.

## SEC filing metadata
- accession: 0001493152-24-004783
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2024-02-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315224004783/0001493152-24-004783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315224004783/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-004783
- JSON: https://secwatch.observer/filing/0001493152-24-004783.json
- Plain text: https://secwatch.observer/filing/0001493152-24-004783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.